[HTML][HTML] Anti-hepatitis B Virus Treatment with Tenofovir Amibufenamide Has No Impact on Blood Lipids: A Real-world, Prospective, 48-week Follow-up Study
Y Chen, W Gao, H Chu, AAM Al-Asbahi… - Journal of Clinical …, 2024 - pmc.ncbi.nlm.nih.gov
Background and Aims The effect of tenofovir amibufenamide (TMF) on blood lipid profiles in
patients with chronic hepatitis B (CHB) remains unclear. This study aimed to explore …
patients with chronic hepatitis B (CHB) remains unclear. This study aimed to explore …
Anti-hepatitis B Virus Treatment with Tenofovir Amibufenamide Has No Impact on Blood Lipids: A Real-world, Prospective, 48-week Follow-up Study.
Y Chen, W Gao, H Chu, AAM Al-Asbahi… - Journal of Clinical …, 2024 - europepmc.org
Methods A total of 91 patients with CHB undergoing TMF treatment for 48 weeks were
divided into two groups: Lipid Normal (n= 42) and Lipid Abnormal (n= 49), based on …
divided into two groups: Lipid Normal (n= 42) and Lipid Abnormal (n= 49), based on …
Anti-hepatitis B Virus Treatment with Tenofovir Amibufenamide Has No Impact on Blood Lipids: A Real-world, Prospective, 48-week Follow-up Study
Y Chen, W Gao, H Chu… - Journal of clinical …, 2024 - pubmed.ncbi.nlm.nih.gov
Background and aims The effect of tenofovir amibufenamide (TMF) on blood lipid profiles in
patients with chronic hepatitis B (CHB) remains unclear. This study aimed to explore …
patients with chronic hepatitis B (CHB) remains unclear. This study aimed to explore …
[PDF][PDF] Anti-hepatitis B Virus Treatment with Tenofovir Amibufenamide Has No Impact on Blood Lipids: A Real-world, Prospective, 48-week Follow-up Study
Y Chen, W Gao, H Chu, AAM Al-Asbahi… - Journal of Clinical …, 2024 - researchgate.net
Abstract Background and Aims: The effect of tenofovir amibufenamide (TMF) on blood lipid
profiles in patients with chronic hepatitis B (CHB) remains unclear. This study aimed to …
profiles in patients with chronic hepatitis B (CHB) remains unclear. This study aimed to …
[HTML][HTML] Anti-hepatitis B Virus Treatment with Tenofovir Amibufenamide Has No Impact on Blood Lipids: A Real-world, Prospective, 48-week Follow-up Study
Y Chen, W Gao, H Chu, AAM Al-Asbahi… - Journal of Clinical …, 2024 - xiahepublishing.com
Methods A total of 91 patients with CHB undergoing TMF treatment for 48 weeks were
divided into two groups: Lipid Normal (n= 42) and Lipid Abnormal (n= 49), based on …
divided into two groups: Lipid Normal (n= 42) and Lipid Abnormal (n= 49), based on …
[HTML][HTML] Anti-hepatitis B Virus Treatment with Tenofovir Amibufenamide Has No Impact on Blood Lipids: A Real-world, Prospective, 48-week Follow-up Study
Y Chen, W Gao, H Chu, AAM Al-Asbahi… - Journal of Clinical …, 2024 - xiahepublishing.com
Methods A total of 91 patients with CHB undergoing TMF treatment for 48 weeks were
divided into two groups: Lipid Normal (n= 42) and Lipid Abnormal (n= 49), based on …
divided into two groups: Lipid Normal (n= 42) and Lipid Abnormal (n= 49), based on …